Treating complex femoropopliteal lesions

J Cardiovasc Surg (Torino). 2018 Apr;59(2):158-163. doi: 10.23736/S0021-9509.18.10374-0. Epub 2018 Jan 9.

Abstract

Peripheral artery disease affects 202 million patients worldwide and may cause disabling intermittent claudication and critical limb ischemia. Next to life style changes, best medical treatment and supervised exercise therapy, it can be necessary to re-vascularize the limb. Treatment of femoropopliteal lesions poses a challenge and a surgical bypass remains recommended in the guidelines for longer and more complex lesions. Bypass surgery is associated with substantial morbidity and even mortality. Endovascular alternatives are quickly evolving from plain balloon angioplasty to drug-eluting stents, drug-coated balloons, polytetrafluoroethylene-covered stents and atherectomy. These developments might challenge the gold standard in the near future. This article focuses on which technique can be used for which femoropopliteal lesion, particularly complex lesions, and summarizes the most recent and important literature on this topic.

Publication types

  • Review

MeSH terms

  • Angioplasty, Balloon* / adverse effects
  • Angioplasty, Balloon* / instrumentation
  • Atherectomy* / adverse effects
  • Coated Materials, Biocompatible
  • Drug-Eluting Stents
  • Endarterectomy* / adverse effects
  • Femoral Artery / physiopathology
  • Femoral Artery / surgery*
  • Humans
  • Intermittent Claudication / diagnosis
  • Intermittent Claudication / physiopathology
  • Intermittent Claudication / therapy*
  • Ischemia / diagnosis
  • Ischemia / physiopathology
  • Ischemia / therapy*
  • Peripheral Arterial Disease / diagnosis
  • Peripheral Arterial Disease / physiopathology
  • Peripheral Arterial Disease / therapy*
  • Polytetrafluoroethylene / chemistry
  • Popliteal Artery / physiopathology
  • Popliteal Artery / surgery*
  • Treatment Outcome
  • Vascular Access Devices
  • Vascular Grafting* / adverse effects
  • Vascular Patency

Substances

  • Coated Materials, Biocompatible
  • Polytetrafluoroethylene